-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GrySPiJVu4EovUb5+xxz6klV4iVY0FsBwtf9OpBEPaNDxMB69CIre7bQgaOeJ8Ml
 j0ZR91P9X11mQjiD5LPmgg==

<SEC-DOCUMENT>0001016504-09-000025.txt : 20091028
<SEC-HEADER>0001016504-09-000025.hdr.sgml : 20091028
<ACCEPTANCE-DATETIME>20091028141221
ACCESSION NUMBER:		0001016504-09-000025
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090123
FILED AS OF DATE:		20091028
DATE AS OF CHANGE:		20091028

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			KAY E GERALD
		CENTRAL INDEX KEY:			0001053310

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31668
		FILM NUMBER:		091141300

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRATED BIOPHARMA INC
		CENTRAL INDEX KEY:			0001016504
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				222407475
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205
		BUSINESS PHONE:		9739260816

	MAIL ADDRESS:	
		STREET 1:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRATED HEALTH TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20020912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEM INTERNATIONAL INC
		DATE OF NAME CHANGE:	19960716
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>geraldkay_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2009-01-23</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001016504</issuerCik>
        <issuerName>INTEGRATED BIOPHARMA INC</issuerName>
        <issuerTradingSymbol>INBP.OB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001053310</rptOwnerCik>
            <rptOwnerName>KAY E GERALD</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>INTEGRATED BIOPHARMA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>225 LONG AVENUE, BLDG 15</rptOwnerStreet2>
            <rptOwnerCity>HILLSIDE</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07205</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>CEO and President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>.15</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2009-01-23</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>100000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2013-12-18</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>100000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>100000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option vests in three equal annual installments beginning on December 18, 2010.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/E Gerald Kay</signatureName>
        <signatureDate>2009-10-28</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----